Keyphrases
Nasal Epithelium
100%
Lubiprostone
100%
Dual Activation
100%
CLCN2
100%
Chloride Efflux
27%
Cystic Fibrosis
18%
Chloride Channel
18%
Pharmacological Activators
18%
Difference Test
18%
Nasal Potential Difference
18%
Peptide Inhibitor
9%
Potential Alternatives
9%
Overexpressing
9%
Overexpression
9%
Transgenic Mouse Model
9%
Alternative Pathway
9%
Clinical Benefit
9%
Aerosol
9%
Fluid Homeostasis
9%
Airway
9%
Sodium Channel
9%
Apical Surface
9%
Hyperpolarization
9%
Chloride Secretion
9%
Doxycycline
9%
Nasal Epithelial Cells
9%
Chloride Transport
9%
Cftr
9%
Efflux Channel
9%
CFTR Inhibitor
9%
GlyH-101
9%
Medicine and Dentistry
Lubiprostone
100%
CLCN2
100%
Effusion
27%
Patient with Cystic Fibrosis
18%
Chloride Channel
18%
Transgenic Mouse
9%
Homeostasis
9%
Secretion (Process)
9%
Epithelial Cell
9%
Doxycycline
9%
Chloride Transport
9%
Reading Test
9%
Sodium Channel
9%
Transgene
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lubiprostone
100%
Effusion
50%
Cystic Fibrosis
33%
Chloride Channel
33%
Transgenic Mouse
16%
Mouse Model
16%
Sodium Channel
16%
Doxycycline
16%